Comparison of Betaferon®, Avonex® and Rebif® in treatment of relapsing-remitting multiple sclerosis

被引：0
|
作者：
Shaygannejad, V. [1 ]
Etemadifar, M. [1 ]
Fereshteh, A. [1 ]
机构：
[1] Isfahan Univ, Esfahan, Iran
来源：
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis
    Etemadifar, M
    Janghorbani, M
    Shaygannejad, V
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (05): : 283 - 287
  • [2] Cytokine patterns after therapy with Avonex®, Rebif®, Betaferon® and CinnoVex™ in relapsing-remitting multiple sclerosis in Iranian patients
    Arababadi, Mohammad Kazemi
    Mosavi, Reza
    Khorramdelazad, Hossein
    Yaghini, Narges
    Zarandi, Ebrahim Rezazadeh
    Araste, Majid
    Pourali, Reza
    Nekhei, Zohre
    Kennedy, Derek
    [J]. BIOMARKERS IN MEDICINE, 2010, 4 (05) : 755 - 759
  • [3] Rationale and design of the prospective and retrospective observational study of Avonex and Rebif (PROOF) for the treatment of relapsing-remitting multiple sclerosis
    Murray, TJ
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (01) : 25 - 30
  • [4] Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis
    Mokhber, Naghmeh
    Azarpazhooh, Amir
    Orouji, Elias
    Khorram, Bita
    Gharavi, Morteza Modares
    Kakhi, Sorayya
    Khallaghi, Hoda
    Azarpazhooh, Mahmoud Reza
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 69 (10) : 649 - 657
  • [5] Comparison of immunomodulatory therapies in treatment of relapsing-remitting multiple sclerosis
    Aydin Canturk, I.
    Isik, N.
    Unsal, A.
    Arici, O.
    Yildiz, N.
    Candan, F.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S96 - S96
  • [6] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [7] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [8] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [9] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    [J]. IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [10] Considerations in the treatment of relapsing-remitting multiple sclerosis
    Calabresi, PA
    [J]. NEUROLOGY, 2002, 58 (08) : S10 - S22
12345